Capital Asset Advisory Services’s iShares US Medical Devices ETF IHI Stock Holding History

Capital Asset Advisory Services’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	51,859 +2,007	+4%	+$118K	0.11%	103
2025 Q4	$3.21M	Sell	49,852 -1,170	-2%	-$72.2K	0.13%	95
2025 Q3	$3.07M	Buy	51,022 +633	+1%	+$38.7K	0.13%	95
2025 Q2	$3.15M	Sell	50,389 -25,349	-33%	-$1.52M	0.15%	88
2025 Q1	$4.57M	Sell	75,738 -2,612	-3%	-$162K	0.23%	56
2024 Q4	$4.63M	Sell	78,350 -369	-0.5%	-$21.9K	0.23%	57
2024 Q3	$4.58M	Buy	78,719 +2,508	+3%	+$143K	0.23%	57
2024 Q2	$4.21M	Buy	76,211 +4,173	+6%	+$234K	0.23%	56
2024 Q1	$4.13M	Buy	72,038 +2,506	+4%	+$142K	0.24%	52
2023 Q4	$3.75M	Buy	69,532 +2,797	+4%	+$137K	0.23%	55
2023 Q3	$3.1M	Buy	66,735 +2,441	+4%	+$130K	0.21%	58
2023 Q2	$3.65M	Buy	64,294 +2,545	+4%	+$140K	0.26%	46
2023 Q1	$3.33M	Buy	61,749 +4,097	+7%	+$218K	0.25%	45
2022 Q4	$3.04M	Buy	57,652 +11,116	+24%	+$564K	0.24%	50
2022 Q3	$2.2M	Buy	46,536 +1,328	+3%	+$68.9K	0.29%	45
2022 Q2	$2.28M	Buy	45,208 +1,603	+4%	+$87.4K	0.25%	59
2022 Q1	$2.66M	Buy	43,605 +2,042	+5%	+$122K	0.28%	50
2021 Q4	$2.74M	Buy	41,563 +1,648	+4%	+$106K	0.29%	48
2021 Q3	$2.51M	Buy	39,915 +1,443	+4%	+$92.1K	0.28%	54
2021 Q2	$2.31M	Sell	38,472 -16,254	-30%	-$940K	0.25%	57
2021 Q1	$3.01M	Sell	54,726 -6	-0%	-$333	0.45%	37
2020 Q4	$2.99M	Sell	54,732 -5,070	-8%	-$265K	0.53%	26
2020 Q3	$2.99M	Buy	59,802 +1,278	+2%	+$61.9K	0.63%	27
2020 Q2	$2.82M	Buy	58,524 +9,582	+20%	+$409K	0.61%	26
2020 Q1	$2.08M	Sell	48,942 -234	-0.5%	-$9.85K	0.55%	35
2019 Q4	$2.24M	Buy	49,176 +8,352	+20%	+$351K	0.53%	36
2019 Q3	$1.68M	Buy	40,824 +17,760	+77%	+$727K	1.12%	16
2019 Q2	$925K	Buy	+23,064	New	+$873K	0.71%	31

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital Asset Advisory Services's IHI Position: Q1 2026 in Review

Capital Asset Advisory Services increased its iShares US Medical Devices ETF (IHI) stake by 4% in Q1 2026, buying an estimated $118K and bringing the position to 51,859 shares worth $2.79M. The position accounts for 0.11% of the portfolio, ranked #103.

Capital Asset Advisory Services first reported a position in IHI in Q2 2019 and has held it in 28 quarters since. The position peaked at $4.63M in Q4 2024. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Capital Asset Advisory Services held 51,859 shares of iShares US Medical Devices ETF worth $2.79M as of Q1 2026.
Capital Asset Advisory Services bought 2,007 iShares US Medical Devices ETF shares in Q1 2026, an estimated $118K.
iShares US Medical Devices ETF made up 0.11% of Capital Asset Advisory Services's portfolio in Q1 2026, its #103 holding.
Capital Asset Advisory Services first reported a position in iShares US Medical Devices ETF in Q2 2019 and has held it in 28 quarters since.
Capital Asset Advisory Services's iShares US Medical Devices ETF position peaked at $4.63M in Q4 2024.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.